T1	Participants 348 440	secondary prevention of clinical events in non-ST-segment elevation acute coronary syndromes
T2	Participants 462 568	240 patients with either unstable angina or non-ST-elevation myocardial infarction in the previous 2 weeks
T3	Participants 1169 1290	secondary prevention of cardiovascular events in patients with unstable angina and non-ST-elevation myocardial infarction
